Dr. Reddy’s Laboratories Ltd., an Indian pharma major, has unveiled its robust performance metrics for the Q2 FY24, ending September 30, 2023. Under the guidelines of the International Financial Reporting Standards (IFRS), the pharmaceutical giant reported a notable YoY revenue growth of 9%, emphasizing its strong market positioning. The company’s growth trajectory, especially in regions […]
Dr. Reddy’s Laboratories has reported a 1% drop in its profit after tax for the first quarter of the fiscal year 2022 (Q1 FY22) to INR 571 crores ($77 million), compared to INR 579 crores ($78 million) in the same quarter of the previous fiscal year. The Indian pharma giant had diluted earnings per share […]
Dr. Reddy’s Laboratories has launched the Sputnik V Covid vaccine in India with the first dose of the Russian vaccine administered today in Hyderabad. The soft launch of the Russian coronavirus vaccine follows the landing of the first batch of its imported doses in India earlier this month and the subsequent regulatory clearance from the […]
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from the Drugs Controller General of India (DCGI). The Indian pharma company, as part of the review process, will provide the safety profile of the phase 2 trial and interim data […]
Dr. Reddy’s Laboratories has secured the go-ahead from the Drugs Control General of India (DCGI) to begin phase 3 clinical trial for the Russian Covid-19 vaccine Sputnik V in India. The Indian pharma company plans to hold the phase 3 study on 1500 volunteers as part of the randomized, double-blind, parallel-group, placebo-controlled study. G V […]
Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India by meeting the primary endpoint of safety. An independent data and safety monitoring board (DSMB) has recommended the Sputnik V Covid-19 vaccine to be advanced to a phase 3 trial […]
Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution of the Sputnik V coronavirus vaccine in India. After receiving regulatory approval in India, the Russian sovereign wealth fund will supply 100 million doses of the vaccine to Dr. Reddy’s. The Sputnik V coronavirus vaccine, which is […]